Structure via PubChem · Public domain (PubChem)
7-ethyl-10-hydroxycamptothecin
Sign in to saveAlso known as SN 38 lactone, 10-Hydroxy-7-ethylcamptothecin, 7-Ethyl-10-hydroxy-20(S)-camptothecin, SN 38
SN-38 is an antineoplastic drug. It is the active metabolite of irinotecan (an analog of camptothecin - a topoisomerase I inhibitor) but has 1000 times more activity than irinotecan itself. In vitro cytotoxicity assays show that the potency of SN-38 relative to irinotecan varies from 2- to 2000-fold.
Chemical data
- Formula
- C22H20N2O5
- Molecular weight
- 392.4 g/mol
- IUPAC name
- (19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione
- SMILES
- CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)O
- InChIKey
- FJHBVJOVLFPMQE-QFIPXVFZSA-N
- XLogP
- 1.4
- Polar surface area
- 100 Ų
- H-bond donors
- 2
- H-bond acceptors
- 6
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 2
- Molecule type
- Small molecule
- Indications
- small cell lung carcinoma, breast cancer, lung cancer, cancer
via ChEMBL · EBI
Wikidata facts
- Subclass of
- alkaloid
- Mass
- 392.137222
Show 3 more facts
- chemical formula
- C₂₂H₂₀N₂O₅
- isomeric SMILES
- CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O
- canonical SMILES
- CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O
Sources (5)
via Wikidata · CC0
~2 min read
Encyclopedic overview
4 sectionsContents
- Use in antibody-drug conjugates
- Interactive pathway map
- See also
- References
SN-38 is an antineoplastic drug. It is the active metabolite of irinotecan (an analog of camptothecin - a topoisomerase I inhibitor) but has 1000 times more activity than irinotecan itself. In vitro cytotoxicity assays show that the potency of SN-38 relative to irinotecan varies from 2- to 2000-fold.
SN38 is formed via hydrolysis of irinotecan by carboxylesterases and metabolized via glucuronidation by UGT1A1.
Excerpted from Wikipedia’s “7-ethyl-10-hydroxycamptothecin” article, available under the CC BY-SA 4.0 licence.